1st Quarter - Report

KNIGHT CAPITOL CONSULTANTS for EQUASHIELD, LLC

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Labor Issues/Antitrust/Workplace LBR

Efforts to ensure worker safety in the administration of hazardous chemicals (no specific legislation).

Foreign entity interest: Equashield Medical, LTD is the parent company of Equashield, LLC

LobbyistCovered position, as disclosed
PATRICIA KNIGHT Chief of Staff, Senator Orrin G. Hatch; Health Policy Director, Senator Orrin G. Hatch

Contacted: Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES; SENATE

Pharmacy PHA

Vial reuse provisions of the Prescription Drug Pricing Reduction Act of 2019 (S. 2543)

Foreign entity interest: Equashield Medical, LTD is the parent company of Equashield, LLC

LobbyistCovered position, as disclosed
PATRICIA KNIGHT Chief of Staff, Senator Orrin G. Hatch

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC)

Bills named: S. 2543 (116th)

Budget/Appropriations BUD

Worker safety issues in any Labor-HHS Appropriations bill (no legislation yet)

Foreign entity interest: Equashield Medical, LTD is the parent company of Equashield, LLC

LobbyistCovered position, as disclosed
PATRICIA KNIGHT Chief of Staff, Senator Orrin G. Hatch

Contacted: HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.